Nuclear receptor action involved with sex differentiation
| LEADER | caa a22 4500 | ||
|---|---|---|---|
| 001 | 378861344 | ||
| 003 | CHVBK | ||
| 005 | 20180305123347.0 | ||
| 007 | cr unu---uuuuu | ||
| 008 | 161128e20030101xx s 000 0 eng | ||
| 024 | 7 | 0 | |a 10.1351/pac200375111771 |2 doi |
| 035 | |a (NATIONALLICENCE)gruyter-10.1351/pac200375111771 | ||
| 245 | 0 | 0 | |a Nuclear receptor action involved with sex differentiation |h [Elektronische Daten] |c [I. A. Hughes, Howard Martin, Jarmo Jääskeläinen, C. L. Acerini] |
| 520 | 3 | |a Sex determination and differentiation in the male is an orderly sequence of events coordinated by genetic and hormonal factors operating in a time- and concentration-dependent manner. The constitutive sex in mammals is female. Disorders of fetal sex development have provided the means to identify testis-determining genes and the molecular mechanisms of hormone action. Thus, the androgen receptor, a nuclear hormone receptor critical for androgen-induced male sex differentiation, displays unique intra-receptor and protein-protein interactions which, when disturbed, can result in extreme forms of sex reversal. Polymorphic variants are associated with milder disorders of sex development. Against this genetic background, endocrine active substances may further contribute to the underlying causes of an increase in male reproductive tract disorders. | |
| 540 | |a © 2013 Walter de Gruyter GmbH, Berlin/Boston | ||
| 700 | 1 | |a Hughes |D I. A. |u Department of Paediatrics, University of Cambridge, Addenbrooke 's Hospital, Box 116, Cambridge CB2 2QQ, UK |4 aut | |
| 700 | 1 | |a Martin |D Howard |u Department of Paediatrics, University of Cambridge, Addenbrooke 's Hospital, Box 116, Cambridge CB2 2QQ, UK |4 aut | |
| 700 | 1 | |a Jääskeläinen |D Jarmo |u Department of Paediatrics, University of Cambridge, Addenbrooke 's Hospital, Box 116, Cambridge CB2 2QQ, UK |4 aut | |
| 700 | 1 | |a Acerini |D C. L. |u Department of Paediatrics, University of Cambridge, Addenbrooke 's Hospital, Box 116, Cambridge CB2 2QQ, UK |4 aut | |
| 773 | 0 | |t Pure and Applied Chemistry |d De Gruyter |g 75/11-12(2003-01-01), 1771-1784 |x 0033-4545 |q 75:11-12<1771 |1 2003 |2 75 |o pac | |
| 856 | 4 | 0 | |u https://doi.org/10.1351/pac200375111771 |q text/html |z Onlinezugriff via DOI |
| 908 | |D 1 |a research article |2 jats | ||
| 950 | |B NATIONALLICENCE |P 856 |E 40 |u https://doi.org/10.1351/pac200375111771 |q text/html |z Onlinezugriff via DOI | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Hughes |D I. A. |u Department of Paediatrics, University of Cambridge, Addenbrooke 's Hospital, Box 116, Cambridge CB2 2QQ, UK |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Martin |D Howard |u Department of Paediatrics, University of Cambridge, Addenbrooke 's Hospital, Box 116, Cambridge CB2 2QQ, UK |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Jääskeläinen |D Jarmo |u Department of Paediatrics, University of Cambridge, Addenbrooke 's Hospital, Box 116, Cambridge CB2 2QQ, UK |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Acerini |D C. L. |u Department of Paediatrics, University of Cambridge, Addenbrooke 's Hospital, Box 116, Cambridge CB2 2QQ, UK |4 aut | ||
| 950 | |B NATIONALLICENCE |P 773 |E 0- |t Pure and Applied Chemistry |d De Gruyter |g 75/11-12(2003-01-01), 1771-1784 |x 0033-4545 |q 75:11-12<1771 |1 2003 |2 75 |o pac | ||
| 900 | 7 | |b CC0 |u http://creativecommons.org/publicdomain/zero/1.0 |2 nationallicence | |
| 898 | |a BK010053 |b XK010053 |c XK010000 | ||
| 949 | |B NATIONALLICENCE |F NATIONALLICENCE |b NL-gruyter | ||